ABSTRACT
Objective:Based on the hyperlipidemia rat model and network pharmacology technology, the mechanism of action of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs against hyperlipidemia was analyzed. Method:The levels of blood lipids and inflammatory factors were measured through prophylactic administration of low, medium and high-dose Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs in hyperlipidemia rats. The active ingredients of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs were screened out through Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP) and text mining. The targets of active ingredients screened through the Swiss Target Prediction, Similarity ensemble approach (SEA), DrugBank database. The disease targets were collected through Therapeutic Target Database (TTD), Online Mendelian Inheritance in Man (OMIM), DrugBank, DisGeNET database. The targets of active ingredients and disease target were integrated, and screened through topological parameters to gain the main candidate targets of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs against hyperlipidemia. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and the gene ontology (GO) functional enrichment analysis were conducted through ClueGO and Database for Annotation, Visualization and Integrated Discovery (DAVID), respectively. The traditional Chinese medicine-chemical ingredient-target network model, and the target-pathway network model were constructed through Cytoscape, and their crosstalk target and signal pathway were analyzed. Result:Animal experiments showed that the prophylactic administration of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs significantly reduced the levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C) in serum of rats with hyperlipidemia, increased high-density lipoprotein (HDL-C) levels, and inhibited the expressions of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). According to the findings, 27 active ingredients, such as mandenol, diosmetin and α-spinasterol, might be the main active ingredients of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs, 16 crosstalk targets and 10 signal pathways might be the main therapeutic targets and pathways, main targeting apolipoprotein A1 (APOA1), apolipoprotein A2 (APOA2), apolipoprotein C3 (APOC3), lipoprotein lipase (LPL), low-density lipoprotein receptor (LDLR) and other crosstalk targets affected cholesterol metabolism, bile secretion, peroxisome proliferator activated receptor (PPAR) signaling pathway in regulating the lipid level, targeting tumor necrosis factor (TNF), IL-6, interleukin-1β (IL-1β), mitogen-activated protein kinase 1 (MAPK1), C-C motif chemokine 2 (CCL2) and other crosstalk targets affected tumor necrosis factor (TNF) signaling pathway, Toll-like receptor signaling pathway, interleukin-17 (IL-17) signaling pathway, and hypoxia inducible factor (HIF) signaling pathway in regulating the inflammatory factor level. The DAVID database for GO enrichment analysis showed that the hyperlipidemia was treated mainly through biological processes, such as inflammation, lipid localization, storage and lipid metabolism. Conclusion:These findings can predict the mechanism of action of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs against hyperlipidemia, and provide a theoretical basis for the material basis and clinical application of Trichosanthis Fructus-Allii Macrostemonis Bulbus herb pairs.
ABSTRACT
OBJECTIVE@#To explore the accuracy of periapical film in evaluating the infrabone root surface area of single-root teeth with different types of resorption of the alveolar bone.@*METHODS@#In this study, the medical records and imaging data of patients in Department of Periodontology of Peking University Hospital of Stomatology from January 2014 to December 2016 were retrospectively analysed. The involved teeth were divided into two groups: horizontal bone loss group and vertical bone loss group. Digital three-dimensional models of teeth were segmented from cone beam computed tomography (CBCT) data, and the percentage of the infrabone root surface area was measured. While the percentage of the residual alveolar bone was measured on the periapical films. The correlation of the two percentages were analyzed, and the differences between the two percentages of each group were compared.@*RESULTS@#Thirty-two patients and 79 single-root teeth were involved totally, in whom there were 25 men and 7 women, aged 26-60 years, and of which there were 41 teeth in the horizontal bone loss group and 38 teeth in the vertical bone loss group. The remaining alveolar bone height percentages were 45.13%-90.39% on the periapical films, and at the same time, the infrabone root surface area percentages were 36.27%-93.03% on CBCT. The residual alveolar bone height percentage of the horizontal bone loss group was not subject to normal distribution, so the residual alveolar bone height percentage and the infrabone root surface area percentage were analyzed by Wilcoxon matched pair rank test (P=0.382), and the result showed no statistically significant difference. The mean value of difference value of the two measurements was 0, and the consistency limit of 95 % was -9.7%-9.8%, between the clinical consistency limit (-15%-15%).The residual alveolar bone height percentage and the infrabone root surface area percentage of the vertical bone loss group were analyzed by paired T test (P< 0.001), and the result showed statistically significant difference. The mean value of difference value of the two measurements was 7.2 %, and the consistency limit of 95% was -13.1%-27.5%, beyond clinical consistency limit (-15%-15%).@*CONCLUSION@#For the teeth with horizontal bone loss, the proximal residual alveo-lar bone height reflected on the periapical films could show the infrabone root surface area relatively accurately. For the teeth with vertical bone loss, the periapical films could not show the degree of periodontal tissue loss accurately, and it would underestimate the extent of bone destruction usually, so CBCT might be taken to show the bone destruction condition of this type of teeth if necessary.